Sponsors
The bill increases operational safety and deterrence by screening and randomly testing SGEs for drug use, at the cost of potential employment losses for appointees, privacy and due‑process concerns, reduced short‑term access to outside experts, and added administrative expenses.
Federal agencies will screen prospective special government employees (SGEs) before they begin service and implement random testing of SGEs in sensitive roles within 90 days, reducing drug-related risks and improving workplace safety and operational reliability in mission‑critical functions.
Clear ineligibility, removal, and a 12‑month reappointment bar create predictable enforcement rules that can deter substance use among SGEs serving in high‑trust roles.
SGEs who test positive face mandatory removal from civil service and a 12‑month bar on reappointment, causing immediate loss of employment and income for affected appointees and contractors.
Mandatory pre‑employment and random drug testing for SGEs may raise privacy and due‑process concerns for appointees (including political appointees) and could be seen as intrusive monitoring of personal medical information.
A positive pre‑employment test can block qualified outside experts from serving for at least 12 months, reducing access to specialized expertise that agencies may need for mission‑critical work.
Based on analysis of 2 sections of legislative text.
Requires pre‑employment and random drug testing for special Government employees in sensitive positions and imposes a 12‑month bar or removal for positive tests.
Introduced April 1, 2025 by Mikie Sherrill · Last progress April 1, 2025
Requires federal agencies to drug‑test special Government employees (SGEs) who hold sensitive positions. Agencies must run pre‑employment drug tests before an SGE’s first day and enroll current SGEs in sensitive roles into a random drug‑testing program within 90 days of enactment; positive tests bar appointments or lead to removal and at least 12 months of ineligibility.